×
This study investigates the use of supervised machine-learning algorithms to support clinicians in classifying amyloidosis and control subjects.
The aim of this work is to foster model interpretability reporting the most important risk factors in predicting the presence of cardiac amyloidosis. We.
People also ask
Automated ML can help identify patients with cardiac amyloidosis and enable prompt and efficient intervention, improving the prognosis in the big data era. A ...
Classification of patients with cardiac amyloidosis using machine learning models on Italian electronic clinical health records. from www.nature.com
May 11, 2021 · We show that the machine learning model performs well in identifying patients with cardiac amyloidosis in the derivation cohort and all four ...
Missing: Italian | Show results with:Italian
Classification of patients with cardiac amyloidosis using machine learning models on Italian electronic clinical health records*. Conference Paper. Jul 2023.
People also search for
Related conditions
For informational purposes only. Consult your local medical authority for advice.
Oct 28, 2024 · A machine-learning model for differential diagnosis between hypertrophic cardiomyopathy, cardiac amyloidosis and Anderson-Fabry disease.
Missing: records. | Show results with:records.
We aimed to develop and validate an artificial intelligence (AI) system for standardised and reliable screening of cardiac amyloidosis-suggestive uptake and ...
Aug 6, 2024 · AI models have demonstrated utility as a diagnostic tool for CA, with comparable or in one case superior efficacy to that of expert cardiologists.
Classification of patients with cardiac amyloidosis using machine learning models on Italian electronic clinical health records*. Conference Paper. Jul 2023.
May 16, 2023 · Our data show that ML might potentially be a useful instrument to identify patients with neuropathy that should undergo genetic testing for ATTRv.
Missing: records. | Show results with:records.